✦ LIBER ✦

Different safety profiles of risperidone and paliperidone extended-release: a double-blind, placebo-controlled trial with healthy volunteers

✍ Scribed by Kil-Sang Yoon; Tae-Won Park; Jong-Chul Yang; Min-Gul Kim; Keun-Young Oh; Myung-Sook Park; Young-Chul Chung

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Neurological, cardiovascular and metabol

✍ TIMOTHY M. E. DAVIS; LAWRENCE G. DEMBO; SALLY A. KAYE-EDDIE; BENJAMIN J. HEWITT; 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 256 KB

A double-blind placebo-controlled trial

✍ L. VINTER-JENSEN; K. KRAGLUND; S. A. PEDERSEN 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 418 KB

A DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL

✍ Carla Canuso; Jennifer Carothers; Bryan Dirks; Young Zhu; Andreas Schreiner; Col 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 61 KB

A double-blind placebo-controlled trial

✍ C. S. ROBERTSON; D. F. EVANS; F. HICKS; M. ATKINSON 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 302 KB

A double-blind, placebo- and positive-in

✍ Ian Hindmarch; Leanne Trick; Fran Ridout 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 160 KB

PR_183: Efficacy and Safety of Oxymorpho

✍ Richard Rauck; Martin E. Hale; Tina Ma; Rosemary Kerwin; Harry Ahdieh 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 55 KB